Articles tagged with Downstream Targets
A study published in Science Translational Medicine found novel biomarkers for tinnitus that correlate with nervous system's 'fight, flight, or freeze' response. Facial movements and pupil dilation measured while listening to unpleasant sounds can predict tinnitus severity.
Bacteria use tactile sensors to detect surfaces and trigger biochemical signals for colonization. Understanding mechanosensing is crucial for improving gut health and preventing biofouling in industries.
Researchers have discovered several novel downstream p53 targets that could lead to improved cancer therapies. The study highlights the critical role of p53 in preventing cancer and identifies two new genes, ALDH3A1 and NECTIN4, as potential targets for cancer treatment.
Researchers from Salk Institute found that specific dietary fats are incorporated into sphingolipids to drive the development of atherosclerotic cardiovascular disease. The team discovered that trans fats are preferentially metabolized by an enzyme, leading to increased lipoprotein secretion and plaque formation.
A study of nearly 2,000 retailers reveals that they tend to disengage from supplier relationships when a direct channel is introduced. This results in a decrease in the number of SKUs ordered and an increase in wholesale prices, with total order value decreasing by €399.50.
Researchers discover PG3 activates p21, PUMA, and DR5 in cancer cells through ATF4 and ISR, independent of p53. The study provides insights into a novel mechanism by which PG3 induces cell death.
Researchers found that targeting and silencing ERBB2 gene expression significantly increases chances of stopping tumor growth in mice with a PTEN mutation. This breakthrough may lead to alternative treatment options for endometrial cancer patients, reducing the risk of fertility issues associated with standard treatments.
A new study uncovers how different people respond to sepsis based on their genetic makeup, which could help identify who would benefit from certain treatments. The research found two groups of patients with opposite immune responses and identified the genetic regulators involved.
Researchers have identified a novel target downstream of parathyroid hormone signaling that suppresses bone formation. Gprc5a negatively regulates osteoblast proliferation and differentiation by partially suppressing BMP signaling, potentially increasing teriparatide effectiveness in non-responding patients.
A new research commentary by Griffith University researchers explores transboundary watersheds and their impact on global biodiversity. The study identifies over 1,050 transboundary watersheds globally, with more than 70% of sediments produced in a different country than the country where they were discharged.
A UTA chemist has developed a new method to separate and recycle mixed plastics using supercritical fluid chromatography. The technique can differentiate oils created from various plastics, holding promise for improving recycling rates and reducing reliance on fossil fuels.
Researchers discovered a link between disrupted developmental dopamine signaling and autism spectrum disorder, highlighting the importance of studying neural development pathways. The study found that dopaminergic signaling disruptions led to neural circuit abnormalities and behavioral phenotypes reminiscent of autism in zebrafish larvae.
A team of researchers at the University of Houston has identified AKAP12 as a promising target for treating heart failure through precision pharmacology. Increased levels of AKAP12 in cardiac myocytes accelerate cardiac dysfunction, but inhibiting PDE8A can reverse this effect and improve contractility.
Researchers at the University of Cincinnati Cancer Center presented abstracts on new potential drugs and targets for treating various types of cancer. A study found that a brain-permeable drug called AM-101 sensitizes brain metastatic tumors to radiation, improving survival in preclinical animal models.
Researchers at Lehigh University found that low- to mid-level flooding events are the most vulnerable to cyber attacks, which can overwhelm the system and cause a flood downstream. The study developed a mathematical framework to identify vulnerabilities in stormwater systems, allowing municipalities to assess their risks.
Researchers developed scSNV-seq to investigate genetic changes affecting gene activity and disease development. The technique accurately assesses the impact of thousands of DNA mutations in cells, providing crucial insights for developing targeted therapies.
Researchers developed a novel assay that integrates data from four fusion callers to identify disease-related gene fusions in pediatric tumors with high accuracy and efficiency. The new bioinformatics platform detected fusions, prioritized them, and custom curated downstream processes for consensus fusion calling.
The Cusack group at EMBL Grenoble has provided insights into the interactions of XIAP and RIPK2 molecules involved in gut signalling pathways. This research sheds light on how these molecules interact, revealing a promising drug target for treating inflammatory bowel diseases.
Researchers classify UGDH as a molecular indicator of tumor progression in multiple cancer types, describing its involvement in key canonical cancer signaling pathways. Methods to inhibit UGDH and its downstream products are also identified.
Researchers propose targeting non-canonical HH/GLI signaling to improve response rate and durability of therapeutic effects exerted by SMO inhibition in melanoma. The findings suggest that combined targeting of hedgehog signaling and BRD4 could provide a novel therapeutic option against melanoma.
Researchers found that a specific neuropeptide affects two separate groups of neurons, promoting aggressive behavior in fruit flies. This discovery provides new insights into the complex mechanisms of neuronal communication using neuropeptides.
Researchers at Georgia Institute of Technology developed a synthetic tumor model to understand the impact of microenvironment on targeted therapies for Activated B Cell-like Diffuse Large B cell lymphoma. The model showed promise in demonstrating how combining therapeutics can overcome tumor resistance to inhibitors.
Researchers investigated the effects of everolimus on the STAT3/HIF-1α/VEGF pathway in TP53 mutant cell lines and xenograft models. Everolimus treatment significantly inhibited cell growth and reduced tumor angiogenesis and lymphangiogenesis.
Researchers found that the F-box gene FBXC-58 is a novel mediator of dietary restriction effects on extending the health span of Caenorhabditis elegans. FBXC-58 prevents muscle aging and extends longevity through an S6 kinase-dependent pathway.
Researchers at Scripps Research Institute have found a major clue to the mystery of hemorrhagic fever syndromes, linking them to the body's antiviral response and identifying Interferon Type I proteins as key drivers of disease. Blocking IFN-I signaling may be a good therapeutic strategy against hemorrhagic fevers.
A gene involved in forming blood vessels has been identified as a key player in DiGeorge syndrome, a chromosomal abnormality causing devastating birth defects. The study found that abnormalities in VEGF lead to the syndrome, which affects the heart, thymus, parathyroid gland, and mental retardation.